China Stocks Lift Hang Seng Above 20,000

Gene Linn |

China Stocks Lift Hang Seng Above 20,000China stocks bounced above a key level in Hong Kong Wednesday on encouraging news from China and abroad.

Hong Kong’s Hang Seng Index rose 1.1% to 20,075 in higher turnover. The index had been stuck below 20,000 since mid-August when hopes for imminent monetary easing in Europe faded. The index of Chinese stocks climbed 1.2% to 9,489.

On the European front investors were relieved when the German high court opened the door for a rescue fund for debt-ridden regional economies. The decision won’t solve the massive debt problem, but was a necessary step in the process. More news is expected from a meeting of the U.S. Federal Reserve Board this week, with investors hoping for another round of quantitative easing.

China added to the feel-good atmosphere Wednesday by announcing in would launch new measure worth RMB 100 billion to boost its sagging economy. Details aren’t available yet, but Francis Lun, managing director at Lyncean Securities, said some of the money may go to higher rebates for the hard-hit exporting sector. That would help companies like Foxconn (FXCNY).

China Railway Construction (CRWOY) and other construction companies will also likely benefit, he told Equities. End

DAILY FIX

Hong Kong Blue Chips: +218, +1.1%, to 20,075, 09-12-12, Hang Seng Index

Chinese Stocks in Hong Kong: +111, +1.2, to 9,489, 09-12-12, HSCE Index

Shanghai Stocks: +6, +0.3% to 2,127, 09-12-12, Shanghai Composite Index.

Chinese Stocks in the U.S.: +5.9, 364.4, 09-11-12, Bank of New York Mellon, ADR Index-China

Insight: Hong Kong blue chips regained the 20,000 level, following Asian and Mainland markets higher. Zoomlion (ZLIOY) and other construction companies rose. KGI Research

Quotable: "We expect the Hang Seng Index to move between 19,200 and 20,300 in September." Guoco Capital. 9-11-12

Chinese Company to Watch: "BUY China State Construction (CCOHY) on better-than-expected contract acquisition." Guoco Capital. 9-11-12

Brokerages and analysts cited here have disclaimers on their websites emphasizing their statements are for information only. They do not endorse my blog, and I don’t endorse them.

For a list of Chinese companies sold in the U.S. and information on each company go to http://www.adrbnymellon.com/dr_country_profile.jsp?country=CN

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
ALB:CA Allbanc Split Corp. II Class A Capital Shares 23.60 0.00 0.00 0

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…